Research with human participants

Overview of medical research in the Netherlands

Effects of the protein hydrolysate pep2balance on brain function as assessed by fMRI

Published:
Last updated:

Download: PDF | XML
Ethical review
Approved WMO
Status
Recruitment stopped
Health condition type
Other condition
Study type
Interventional

ID

NL-OMON32485

Source

ToetsingOnline

Brief title

protein hydrolysate pep2balance and brain funtion

Condition

  • Other condition

Health condition

gezonde deelnemers

Research involving

Human

Sponsors and support

Primary sponsor :
DSM Food Specialties
Source(s) of monetary or material Support :
DSM Nutritional products

Intervention

Keyword :
brainfunction, fmri, pep2balance

Outcome measures

Public
DSM Food Specialties

Wurmisweg 576
CH-4303 Kaiseraugst
Switzerland
Scientific
DSM Food Specialties

Wurmisweg 576
CH-4303 Kaiseraugst
Switzerland

Listed location countries

Netherlands

Age

Adults (18-64 years)
Elderly (65 years and older)

Inclusion criteria

Exclusion criteria

Design

Study phase :
2
Study type :
Interventional
Intervention model
:
Crossover
Allocation :
Randomized controlled trial
Masking :
Double blinded (masking used)
Control :
Placebo
Primary purpose :
Treatment

Recruitment

NL
Recruitment status
:
Recruitment stopped
Start date (anticipated) :
Enrollment :
30
Type :
Actual

Approved WMO
Date :
Application type :
First submission
Review commission :
CMO regio Arnhem-Nijmegen (Nijmegen)

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
CCMO NL25361.091.08